BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 3338273)

  • 1. Pathogenesis of hypotension in septic shock: correlation of circulating phospholipase A2 levels with circulatory collapse.
    Vadas P; Pruzanski W; Stefanski E; Sternby B; Mustard R; Bohnen J; Fraser I; Farewell V; Bombardier C
    Crit Care Med; 1988 Jan; 16(1):1-7. PubMed ID: 3338273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of circulating phospholipase A2 in the pathogenesis of the hemodynamic changes in endotoxin shock.
    Vadas P; Hay JB
    Can J Physiol Pharmacol; 1983 Jun; 61(6):561-6. PubMed ID: 6883208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated plasma phospholipase A2 levels: correlation with the hemodynamic and pulmonary changes in gram-negative septic shock.
    Vadas P
    J Lab Clin Med; 1984 Dec; 104(6):873-81. PubMed ID: 6548766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum phospholipase A2 enzyme activity and immunoreactivity in a prospective analysis of patients with septic shock.
    Vadas P; Scott K; Smith G; Rajkovic I; Stefanski E; Schouten BD; Singh R; Pruzanski W
    Life Sci; 1992; 50(11):807-11. PubMed ID: 1740964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concordance of endogenous cortisol and phospholipase A2 levels in gram-negative septic shock: a prospective study.
    Vadas P; Pruzanski W; Stefanski E; Ruse J; Farewell V; McLaughlin J; Bombardier C
    J Lab Clin Med; 1988 May; 111(5):584-90. PubMed ID: 2834477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A predictive model for the clearance of soluble phospholipase A2 during septic shock.
    Vadas P; Pruzanski W; Farewell V
    J Lab Clin Med; 1991 Nov; 118(5):471-5. PubMed ID: 1940588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet-activating factor and phospholipase A2 in patients with septic shock and trauma.
    Sörensen J; Kald B; Tagesson C; Lindahl M
    Intensive Care Med; 1994 Nov; 20(8):555-61. PubMed ID: 7706567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential therapeutic efficacy of inhibitors of human phospholipase A2 in septic shock.
    Vadas P; Stefanski E; Pruzanski W
    Agents Actions; 1986 Nov; 19(3-4):194-202. PubMed ID: 3825740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating phospholipase A2 activity associated with sepsis and septic shock is indistinguishable from that associated with rheumatoid arthritis.
    Green JA; Smith GM; Buchta R; Lee R; Ho KY; Rajkovic IA; Scott KF
    Inflammation; 1991 Oct; 15(5):355-67. PubMed ID: 1757123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoreactive pancreatic phospholipase A2 and catalytically active phospholipases A2 in serum from patients with acute pancreatitis.
    Eskola JU; Nevalainen TJ; Kortesuo P
    Clin Chem; 1988 Jun; 34(6):1052-4. PubMed ID: 3288372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic value of immunoreactive phospholipase A2 in acute pancreatitis.
    Malfertheiner P; Nevalainen T; Uhl W; Schädlich H; Büchler M
    Klin Wochenschr; 1989 Feb; 67(3):183-5. PubMed ID: 2467045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum phospholipase A2 in intensive care patients with peritonitis, multiple injury, and necrotizing pancreatitis.
    Büchler M; Deller A; Malfertheiner P; Kleine HO; Wiedeck H; Uhl W; Samtner M; Friess H; Nevalainen T; Beger HG
    Klin Wochenschr; 1989 Feb; 67(3):217-21. PubMed ID: 2927058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical studies of serum phospholipase A2 immunoreactivity].
    Funakoshi A; Furukawa M; Yamada Y; Wakasugi H; Abe M; Oogami Y; Shinozaki H
    Nihon Shokakibyo Gakkai Zasshi; 1989 May; 86(5):1136-40. PubMed ID: 2795950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phospholipase A2 from plasma of patients with septic shock is associated with high-density lipoproteins and C3 anaphylatoxin: some implications for its functional role.
    Gijón MA; Pérez C; Méndez E; Sánchez Crespo M
    Biochem J; 1995 Feb; 306 ( Pt 1)(Pt 1):167-75. PubMed ID: 7864806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of group II phospholipase A2 expression and pathogenesis of the sepsis syndrome.
    Vadas P; Pruzanski W
    Circ Shock; 1993 Feb; 39(2):160-7. PubMed ID: 8490995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relevance of serum phospholipase A2 assays to the assessment of septic shock.
    Heath MF; Tighe D; Moss R; Bennett ED
    Crit Care Med; 1990 Jul; 18(7):766-7. PubMed ID: 2364720
    [No Abstract]   [Full Text] [Related]  

  • 17. Nitrite/nitrate (NOX) and type II phospholipase A2, leukotriene B4, and platelet-activating factor levels in patients with septic shock.
    Nakae H; Endo S; Inada K; Yaegashi Y; Takakuwa T; Yamada Y; Arakawa N; Suzuki T; Taniguchi S; Shimamura T; Ogawa M; Teraoka H
    Res Commun Mol Pathol Pharmacol; 1996 May; 92(2):131-9. PubMed ID: 8774066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of group II phospholipase A2 in rat brain after severe forebrain ischemia and in endotoxic shock.
    Lauritzen I; Heurteaux C; Lazdunski M
    Brain Res; 1994 Jul; 651(1-2):353-6. PubMed ID: 7922587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum phospholipase A2 activity in chronic pancreatic diseases.
    Basso D; Fabris C; Panozzo MP; Meggiato T; Del Favero G; Naccarato R
    Clin Biochem; 1990 Jun; 23(3):229-32. PubMed ID: 1695558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreatic phospholipase A2 activity in acute pancreatitis: a prognostic marker for early identification of patients at risk.
    Aufenanger J; Samman M; Quintel M; Fassbender K; Zimmer W; Bertsch T
    Clin Chem Lab Med; 2002 Mar; 40(3):293-7. PubMed ID: 12005220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.